De LauLM,BretelerMM, 2006."Epidemiology of Parkinson's disease",Lancet Neurol 5 525 -35
SamiiA,NuttJG,RansomBR, 2004."Parkinson's disease",Lancet 363 1783 -93
JankovicJ, 2008."Parkinson's disease: clinical features and diagnosis",J. Neurol. Neurosurg. Psychiatr 79 368 -76
Barnett-CowanM,DydeRT,FoxeSH,MoroE,HutchisonWD,HarrisLR, 2010."Multisensory determinants of orientation perception in Parkinson's disease",Neuroscience 167 1138 -50
LesageS,BriceA, ."Parkinson's disease: from monogenic forms to genetic susceptibility factors", -
ObesoJA,Rodriguez-OrozMC,GoetzCG, 2010."Missing pieces in the Parkinson's disease puzzle",Nat. Med 16 653 -61
ObesoJA,Rodríguez-OrozMC,BenitezTeminoB, 2008."Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease",Mov. Disord 23 S548 -59
VanMaele-Fabry,G , Hoet,P , Vilain,F , Lison,D., 2012."Occupational exposure to pesticides and Parkinson's disease: a systematic review and meta-analysis of cohort studies",Environ Int 46 30 -43
Brooks DJ, 2010."Imaging approaches to Parkinson disease",J. Nucl. Med 51 596 -609
CostaJ,LunetN,SantosC,SantosJ,VazCarneiroA, 2010."Caffeine exposure and the risk of Parkinson's disease: a systematic review and metaanalysis of observational studies",J. Alzheimers Dis 20 S221 -
QuikM,HuangLZ,ParameswaranN,BordiaT,CamposC,Perez XA, 2009."Multiple roles for nicotine in Parkinson's disease",Biochem Pharmacol 78 677 -85
SuchowerskyO,GronsethG,PerlmutterJ,ReichS,ZesiewiczT,WeinerWJ, 2006."Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology",Neurology 66 976 -82
FahnS,OakesD,ShoulsonI, 2004.Levodopa and the progression of Parkinson's disease,New England Journal of Medicine 351 2498 -2508
BaroneP,BraviD,Bermejo-ParejaF, 1999.Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide M o n o t h e r a p y S t u d y G r o u p . N e u r o l o g y ; 53(3, 573 -579
BirkmayerW,KnollJ,RiedererP, 1985.Increased life expectancy resulting from addition of L-deprenyl to madopar treatment in Parkinson's disease: a longterm study,Journal of Neural Transmission; 64 113 -127
LenzFA,TaskerRR,KwanHC, 1987.Selection of the optimal lesion site for the relief of parkinsonian tremor on the basis of spectral analysis of neuronal firing patterns, 50 338 -43
LimousinP,PollakP,BenazzouzA, 1995.Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation, 345 91 -95